• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病:排列紊乱、纤维化与小血管疾病的相互关系

Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

作者信息

Varnava A M, Elliott P M, Sharma S, McKenna W J, Davies M J

机构信息

Department of Cardiovascular Pathology, St George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, UK.

出版信息

Heart. 2000 Nov;84(5):476-82. doi: 10.1136/heart.84.5.476.

DOI:10.1136/heart.84.5.476
PMID:11040002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1729476/
Abstract

OBJECTIVE

To make a quantitative assessment of the relation between disarray, fibrosis, and small vessel disease in hypertrophic cardiomyopathy.

DESIGN

Detailed macroscopic and histological examination at 19 segments of the left and right ventricle and the left atrial free wall.

PATIENTS

72 patients with hypertrophic cardiomyopathy who had suffered sudden death or progression to end stage cardiac failure (resulting in death or heart transplantation).

MAIN OUTCOME MEASURES

The presence of scarring, atrial dilatation, and a mitral valve impact lesion were noted, and heart weight, wall thickness, per cent disarray, per cent fibrosis, and per cent small vessel disease quantitated for each heart.

RESULTS

Within an individual heart the magnitude of hypertrophy correlated with the severity of fibrosis (p = 0.006) and disarray (p = 0.0002). Overall, however, total heart weight related weakly but significantly to fibrosis (r = 0.4, p = 0.0001) and small vessel disease (r = 0.3, p = 0.03), but not to disarray. Disarray was greater in hearts with mild left ventricular hypertrophy (maximum wall thickness < 20 mm) and preserved systolic function (60.9 (26)% v 43 (20.4)% respectively, p = 0.02) and hearts without a mitral valve impact lesion (26.3% v 18.9%, p = 0.04), but was uninfluenced by sex. Fibrosis was influenced by sex (7% in male patients and 4% in female, p = 0.04), but not by the presence of an impact lesion. No relation was found between disarray, fibrosis, and small vessel disease.

CONCLUSIONS

Myocyte disarray is probably a direct response to functional or structural abnormalities of the mutated sarcomeric protein, while fibrosis and small vessel disease are secondary phenomena unrelated to disarray, but modified by factors such as left ventricular mass, sex, and perhaps local autocrine factors.

摘要

目的

对肥厚型心肌病中肌束紊乱、纤维化和小血管疾病之间的关系进行定量评估。

设计

对左、右心室及左心房游离壁的19个节段进行详细的大体和组织学检查。

患者

72例肥厚型心肌病患者,这些患者经历了猝死或进展为终末期心力衰竭(导致死亡或心脏移植)。

主要观察指标

记录瘢痕形成、心房扩张和二尖瓣撞击病变的存在情况,并对每颗心脏的心脏重量、壁厚、肌束紊乱百分比、纤维化百分比和小血管疾病百分比进行定量。

结果

在个体心脏中,肥厚程度与纤维化严重程度(p = 0.006)和肌束紊乱严重程度(p = 0.0002)相关。然而,总体而言,心脏总重量与纤维化(r = 0.4,p = 0.0001)和小血管疾病(r = 0.3,p = 0.03)呈弱但显著的相关性,但与肌束紊乱无关。在轻度左心室肥厚(最大壁厚<20 mm)且收缩功能保留的心脏中(分别为60.9(26)%和43(20.4)%,p = 0.02)以及没有二尖瓣撞击病变的心脏中(26.3%对18.9%,p = 0.04),肌束紊乱更严重,但不受性别影响。纤维化受性别影响(男性患者为7%,女性为4%,p = 0.04),但不受撞击病变存在的影响。未发现肌束紊乱、纤维化和小血管疾病之间存在关联。

结论

肌细胞紊乱可能是对突变肌节蛋白功能或结构异常的直接反应,而纤维化和小血管疾病是与肌束紊乱无关的继发现象,但受左心室质量、性别以及可能的局部自分泌因子等因素影响。

相似文献

1
Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.肥厚型心肌病:排列紊乱、纤维化与小血管疾病的相互关系
Heart. 2000 Nov;84(5):476-82. doi: 10.1136/heart.84.5.476.
2
Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy.肥厚型心肌病中心肌细胞排列紊乱与预后的关系。
Am J Cardiol. 2001 Aug 1;88(3):275-9. doi: 10.1016/s0002-9149(01)01640-x.
3
Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease.肥厚型心肌病:心肌肌钙蛋白T疾病猝死的组织病理学特征
Circulation. 2001 Sep 18;104(12):1380-4. doi: 10.1161/hc3701.095952.
4
Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy.正常心脏、高血压性心脏及肥厚型心肌病中心肌纤维化的定量分析
Br Heart J. 1986 Jun;55(6):575-81. doi: 10.1136/hrt.55.6.575.
5
Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis.肥厚型梗阻性心肌病的组织病理学特征。心肌纤维排列紊乱和心肌纤维化。
Br Heart J. 1980 Oct;44(4):433-43. doi: 10.1136/hrt.44.4.433.
6
Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy.
Am Heart J. 1985 Mar;109(3 Pt 1):545-53. doi: 10.1016/0002-8703(85)90561-7.
7
Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.症状性梗阻性肥厚型心肌病患者的心肌纤维化:与超声心动图测量、肌节基因型以及涉及肾素-血管紧张素-醛固酮系统的促左心室肥厚多态性的相关性
Cardiovasc Pathol. 2009 Sep-Oct;18(5):262-8. doi: 10.1016/j.carpath.2008.08.003. Epub 2008 Oct 2.
8
[Hypertrophic cardiomyopathy: mode of death and pathological findings].肥厚型心肌病:死亡方式与病理表现
J Cardiol Suppl. 1987;16:3-8.
9
Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.肥厚型心肌病病程中的左心房功能:与左心室肥厚及纤维化的关系
Invest Radiol. 2017 Mar;52(3):177-185. doi: 10.1097/RLI.0000000000000326.
10
[Comparison of regional contractile dynamics and pathological findings of the left ventricular wall in patients with hypertrophic cardiomyopathy].肥厚型心肌病患者左心室壁区域收缩动力学与病理结果的比较
J Cardiol. 1988 Sep;18(3):665-72.

引用本文的文献

1
Deteriorated biomechanical properties of human hypertrophied septum in response to cardiomyocyte enlargement, overexpressed collagen, and disarrayed microstructures.人类肥厚性室间隔的生物力学特性因心肌细胞增大、胶原蛋白过度表达和微观结构紊乱而恶化。
Front Bioeng Biotechnol. 2025 Jun 2;13:1620594. doi: 10.3389/fbioe.2025.1620594. eCollection 2025.
2
Predicting New-Onset Atrial Fibrillation in Hypertrophic Cardiomyopathy: A Review.肥厚型心肌病新发心房颤动的预测:综述
J Clin Med. 2025 Mar 16;14(6):2018. doi: 10.3390/jcm14062018.
3
Understanding Sex Differences in Hypertrophic Cardiomyopathy Surgery: Insights From a Decade-Long Cohort Study From China.了解肥厚型心肌病手术中的性别差异:来自中国一项长达十年队列研究的见解
J Am Heart Assoc. 2025 Mar 4;14(5):e038421. doi: 10.1161/JAHA.124.038421. Epub 2025 Feb 25.
4
Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.《2024年墨西哥肥厚型心肌病诊断与治疗指南》
Arch Cardiol Mex. 2024;94(Supl 4):1-75. doi: 10.24875/ACM.M25000098.
5
Effects of genetic mutations on left ventricular myocardial mechanics and fibrosis patterns in hypertrophic cardiomyopathy.基因突变对肥厚型心肌病左心室心肌力学及纤维化模式的影响。
Sci Rep. 2025 Jan 4;15(1):799. doi: 10.1038/s41598-025-85201-0.
6
Clinical Implications of Pan-Immune-inflammatory Values in Patients with Hypertrophic Cardiomyopathy.肥厚型心肌病患者全免疫炎症指标的临床意义
Medeni Med J. 2024 Dec 27;39(4):254-260. doi: 10.4274/MMJ.galenos.2024.96266.
7
Cardiovascular Computed Tomography and Magnetic Resonance Imaging Guideline of the Brazilian Society of Cardiology and the Brazilian College of Radiology - 2024.巴西心脏病学会和巴西放射学会心血管计算机断层扫描与磁共振成像指南 - 2024年
Arq Bras Cardiol. 2024 Oct 28;121(9):e20240608. doi: 10.36660/abc.20240608.
8
Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy.全面蛋白质组学分析人类心肌组织,揭示肥厚型心肌病中失调的信号通路。
J Am Coll Cardiol. 2024 Nov 12;84(20):1999-2011. doi: 10.1016/j.jacc.2024.07.043. Epub 2024 Oct 2.
9
A guide for assessment of myocardial stiffness in health and disease.健康与疾病状态下心肌僵硬度评估指南。
Nat Cardiovasc Res. 2022 Jan;1(1):8-22. doi: 10.1038/s44161-021-00007-3. Epub 2022 Jan 12.
10
Echocardiographic Strain Abnormalities Precede Left Ventricular Hypertrophy Development in Hypertrophic Cardiomyopathy Mutation Carriers.超声心动图应变异常先于肥厚型心肌病突变携带者左心室肥厚的发展。
Int J Mol Sci. 2024 Jul 25;25(15):8128. doi: 10.3390/ijms25158128.

本文引用的文献

1
Asymmetrical hypertrophy of the heart in young adults.年轻成年人心脏不对称性肥大。
Br Heart J. 1958 Jan;20(1):1-8. doi: 10.1136/hrt.20.1.1.
2
Genotype: phenotype correlations in hypertrophic cardiomyopathy.
Eur Heart J. 1998 Jan;19(1):10-2.
3
A mouse model of familial hypertrophic cardiomyopathy.家族性肥厚型心肌病的小鼠模型
Science. 1996 May 3;272(5262):731-4. doi: 10.1126/science.272.5262.731.
4
Molecular basis of familial cardiomyopathies.家族性心肌病的分子基础。
Circulation. 1995 Jan 15;91(2):532-40. doi: 10.1161/01.cir.91.2.532.
5
Recent advances in the molecular genetics of hypertrophic cardiomyopathy.
Circulation. 1995 Sep 1;92(5):1336-47. doi: 10.1161/01.cir.92.5.1336.
6
Hypertrophic cardiomyopathy and cardiac muscle cell disorganization revisited: relation between the two and significance.
Am Heart J. 1981 Jul;102(1):95-110. doi: 10.1016/0002-8703(81)90419-1.
7
Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis.肥厚型梗阻性心肌病的组织病理学特征。心肌纤维排列紊乱和心肌纤维化。
Br Heart J. 1980 Oct;44(4):433-43. doi: 10.1136/hrt.44.4.433.
8
The current status of myocardial disarray in hypertrophic cardiomyopathy.肥厚型心肌病中心肌排列紊乱的现状
Br Heart J. 1984 Apr;51(4):361-3. doi: 10.1136/hrt.51.4.361.
9
Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings.梗阻性和非梗阻性不对称性室间隔肥厚(ASH)患者心肌异常分布的差异。光镜和电镜检查结果。
Circulation. 1974 Sep;50(3):436-46. doi: 10.1161/01.cir.50.3.436.
10
Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy.肥厚型心肌病中的壁内(“小血管”)冠状动脉疾病。
J Am Coll Cardiol. 1986 Sep;8(3):545-57. doi: 10.1016/s0735-1097(86)80181-4.